Labshake search
Citations for Stemcell Technologies :
251 - 300 of 694 citations for 7 Fluoro 3 oxo 3 4 dihydroquinoxaline 2 carboxylic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2023Quote: ... ascorbic acid (50 μg/ml, STEMCELL Technologies, Cat# ST-72132), 1 × GlutaMAX (Thermo Fisher Scientific ...
-
bioRxiv - Microbiology 2023Quote: ... 2 µl of 2% rat serum (Stemcell technologies) was added to each well for 15 minutes at room temperature and proceeded to further staining without a washing step.
-
bioRxiv - Microbiology 2024Quote: ... Cells were incubated for 7 days submerged in PneumaCult-ExPlus (STEMCELL Technologies, Vancouver, BC, Canada). After the 7-day culture ...
-
bioRxiv - Cancer Biology 2024Quote: ... Cells were visualized at day 7 or 14 using the STEMVision colony counter (STEMCELL Technologies) with manual counting to ensure accuracy.
-
bioRxiv - Neuroscience 2024Quote: ... from day 0 to day 7 and with 100 nM LDN193189 (ref.72147, Stemcell Technologies) from day 7 to day 14 ...
-
bioRxiv - Bioengineering 2021Quote: ... then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
-
bioRxiv - Bioengineering 2021Quote: ... and 10 μM all-trans retinoic acid (RA, STEMCELL Technologies, 72262), and the removal of Glial Cell Derived Neurotrophic Factor (GDNF).
-
bioRxiv - Bioengineering 2021Quote: ... and 0.1 μM all-trans retinoic acid (Stem Cell Technologies; 72262) for 5 days ...
-
bioRxiv - Molecular Biology 2019Quote: ... and 10 µM all-trans retinoic acid (ATRA, Stemcell Technologies, 72264) (Differentiation Medium 1) ...
-
bioRxiv - Genomics 2020Quote: ... All-Trans Retinoic Acid 0.1 μM (RA, STEMCELL Technologies, Cat.: #72262), and Purmorphamine 0.5 μM (PMN ...
-
bioRxiv - Immunology 2021Quote: ... 50 μg/ml L-ascorbic acid (L-AA, Stem Cell Technologies) and 6 μg/ml holo-transferrin (Sigma) ...
-
bioRxiv - Neuroscience 2024Quote: ... 1% minimum essential medium/non-essential amino acid (Stem Cell Technologies), 1% penicillin/streptomycin (Thermo Fisher Scientific) ...
-
bioRxiv - Neuroscience 2024Quote: ... 1% minimum essential medium/non-essential amino acid (Stem Cell Technologies), 20 ng/ml brain-derived neurotrophic factor (ProSpec Bio) ...
-
bioRxiv - Bioengineering 2021Quote: ... and then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 % neomycin and addition of 10 μM retinoic acid (RA) (Stemcell Technologies). At day 6 the cells were washed twice with warm PBS (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2021Quote: ... Cultures were fed every other day and passaged every 5–7 days by ReLeSR™ (STEMCELL Technologies).
-
bioRxiv - Bioengineering 2023Quote: ... The iPSCs were routinely passaged every 5-7 days using ReLeSR™ Passaging Reagent (Stemcell Technologies, Canada). The iPSCs were then differentiated into SCPCs based on a modified protocol to generate spinal motor neurons (Hor et al. ...
-
bioRxiv - Neuroscience 2024Quote: ... embryonic bodies (EBs) were formed for 7 days in mTeSR plus medium in AggreWell plates (Stemcell Technologies) with addition of human recombinant BMP-4 (50 ng/ml ...
-
bioRxiv - Biochemistry 2023Quote: ... Cells were cultured for 7 d at 5% O2 in EpiCult- B mouse medium (STEMCELL Technologies, 05610) supplemented with 5% FBS ...
-
bioRxiv - Microbiology 2020Quote: ... anti-SSEA-4 antibody (STEMCELL Technologies), anti-Sox17 antibody (R&D System) ...
-
bioRxiv - Microbiology 2024Quote: ... 4 µg/mL heparin (STEMCELL Technologies), Pneumacult-ALI maintenance supplement (STEMCELL Technologies ...
-
Autophagy suppression in DNA damaged cells occurs through a newly identified p53-proteasome-LC3 axisbioRxiv - Cell Biology 2024Quote: ... and Valproic Acid (VPA, 10 μM final concentration; #72292, Stem Cell Technologies, Canada) to enrich organoids for stem cells.82 After approximately 5 – 7 days ...
-
bioRxiv - Developmental Biology 2020Quote: ... and pluripotent stem cells were passaged every 5 to 7 days in the ReLeSR medium (Stem Cell Technologies). Pluripotent iPSC and hESC were differentiated into retinal organoids as previously described (9 and Fig S1 ...
-
bioRxiv - Neuroscience 2022Quote: ... Cells were passaged in small aggregates (1:7/1:10 depending on the line) using ReLeSR (StemCell Technologies). 10 μM Y-27632 (ROCK inhibitor ...
-
Arc mediates intercellular synaptic plasticity via IRSp53-dependent extracellular vesicle biogenesisbioRxiv - Neuroscience 2024Quote: ... 2% SM1 (StemCell Technologies), 500 µM L-Glutamine ...
-
bioRxiv - Developmental Biology 2023Quote: ... we added 4-hydroxytamoxifen freshly prepared in ethanol as per manufacturer instructions (4-OHT) (Stem Cell Technologies, 72662) to the medium at 0.1µM at the indicated time points.
-
bioRxiv - Biochemistry 2023Quote: ... 4 μg/mL heparin (STEMCELL Technologies, 07980) and 5 μM ROCK inhibitor (Millipore) ...
-
bioRxiv - Bioengineering 2019Quote: ... and cultured at 37°C (5% CO2) for 7 days in 300 µL StemSpan™ SFEM (#09650 Stemcell Technologies) supplemented with 100 ng/mL SCF (Peprotech ...
-
bioRxiv - Immunology 2021Quote: ... Both cell types were passaged every 7 days or as they reached 70-80% confluency using ReLeSR (STEMCELL Technologies). All iPSC and ESC lines used for these studies are listed in Table 1 along with the method of reprogramming and institution they were reprogrammed at ...
-
bioRxiv - Cell Biology 2024Quote: ... mesoderm was carried out for 5 days and ectoderm for 7 days using STEMdiff Trilineage Differentiation Kit (STEMCELL Technologies). Alternatively ...
-
bioRxiv - Neuroscience 2020Quote: ... Dibutyryl-cAMP (1 mM) and ascorbic acid (200 nM) (STEMCELL Technologies, Vancouver, BC, Canada). Half fresh medium containing Amyloid β Protein Fragment 1-42 (50 nM ...
-
bioRxiv - Developmental Biology 2021Quote: ... Definitive endoderm cells are then differentiated into anterior ventral foregut endoderm (Stage 2) using dual SMAD inhibition for 2 days with 2 µM Dorsomorphin (STEMCELL Technologies, cat#72102) and 10 µM SB431542 (STEMCELL Technologies ...
-
bioRxiv - Biophysics 2023Quote: ... with the addition of Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Immunology 2021Quote: ... The preparation was centrifuged (200 g; 7 min) and the pellet resuspended in PneumaCult-Ex Plus expansion medium (Stemcell Technologies), then seeded onto 25 cm2 tissue culture flasks pre-coated with 30 µg/mL Type I collagen (PureCol ...
-
bioRxiv - Neuroscience 2022Quote: ... NSPC cultures were then passaged every 7 days by enzymatic disaggregation with Accutase (cat# 7920, Stem Cell Technologies, Vancouver, Canada). The medium was supplemented with Neurocult proliferation supplement (cat# 05702 ...
-
bioRxiv - Developmental Biology 2022Quote: ... IPSC colonies were picked and passaged every 5 to 7 days after transfer to the mTeSR culture system (Stemcell Technologies).
-
bioRxiv - Immunology 2024Quote: ... and P14 cells were isolated on 7 dpi using the EasySep Mouse APC Positive Selection Kit II (#17667, STEMcell technologies) with a CD45.2 APC antibody (#17-0454-82 ...
-
bioRxiv - Bioengineering 2019Quote: ... or APEL 2 (STEMCELL Technologies) media without ROCK inhibitor and plates were placed onto LAVA illumination devices and subjected to experimental conditions ...
-
bioRxiv - Neuroscience 2021Quote: ... 2 µM XAV939 (STEMCELL Technologies), 10 µM SB431542 hydrate and 2 µg/mL doxycycline hyclate (Sigma) ...
-
bioRxiv - Pathology 2022Quote: ... 2 µM CHIR99021 (StemCell Technologies), and 10 ng/mL Recombinant Human BMP-7(Peprotech) ...
-
bioRxiv - Cell Biology 2022Quote: ... 2% SM1 (Stem Cell Technologies), 15mM HEPES (Gibco) ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% SM1 (05711, STEMCell Technologies), 1% N2 (07152 ...
-
bioRxiv - Neuroscience 2023Quote: ... IWP-2 (STEMCELL Technologies, 72124), RA (Sigma ...
-
bioRxiv - Bioengineering 2023Quote: ... (StemCell Technologies, #129830-38-2) in mTeSR-1 media ...
-
bioRxiv - Bioengineering 2023Quote: ... (StemCell Technologies, #129830-38-2) in mTeSR-1 media ...
-
bioRxiv - Developmental Biology 2024Quote: ... 2 µM SB431542 (StemCell Technologies), 1 µM DMH1 (Tocris Bioscience) ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 4 µg/mL heparin (STEMCELL Technologies), 480 ng/mL hydrocortisone ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 μg/ml heparin (Stem cell technologies; #07980), 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 µg/mL Heparin (StemCell Technologies, cat. 07980), and 400 nL/mL B27 (Invitrogen ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 µg/mL Heparin (StemCell Technologies, cat. 07980), and 400 nL/mL B27 (Invitrogen ...